Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Matthew ...
Here’s the latest company planning for gene-edited babies The news: A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...
Inside the Booming mRNA Therapeutics MarketThe mRNA Cancer Vaccines and Therapeutics Market has emerged as one of the most transformative frontiers in oncology and biotechnology. These advanced ...
Ghana News Agency on MSN
Genetically modified foods safe and nutritious – CSIR Scientists dispel myths
The Council for Scientific and Industrial Research (CSIR) has assured Ghanaians that Genetically Modified (GM) foods, particularly the Pod Borer Resistant (PBR) cowpea, were safe, nutritious, and ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
About BB-301 BB-301 is a novel, modified AAV9 capsid expressing a unique ... (“Benitec” or the “Company”) is a clinical-stage biotechnology company focused on the advancement of novel genetic ...
To overcome this challenge, it will take farmers like me. We can’t fight in the court of law, but we can make our voices ...
The Director-General and Chief Executive Officer of the National Biosafety Management Agency (NBMA), Bello Bawa Bwari, has reaffirmed the agency’s strong commitment to advancing President Bola Ahmed ...
The apparel industry accounts for 10% of greenhouse gas emissions. Biotechs are working on reengineering natural products to make more sustainable textiles, which are gaining traction.
Flanders Institute for Biotechnology (VIB), biologist Jessie Vandierendonck has been investigating new, alternative ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback